Literature DB >> 16333078

High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.

Paul H M Smits1, Remco Bakker, Eefje Jong, Jan Willem Mulder, Pieter L Meenhorst, Bernhard Kleter, Leen-Jan van Doorn, Wim G V Quint.   

Abstract

Infection with human immunodeficiency virus (HIV) and the resulting immunosuppression are associated with an increased risk for human papillomavirus (HPV) persistence and related malignancies. In the present study we investigated the prevalence of HPV in urine samples from 104 HIV-infected men with low CD4+ cell counts (<100 per mm(3)) and 115 urine samples from HIV-negative men. A high prevalence of HPV DNA (39.4%) was found in the HIV patients. Most of the HPV types were high risk (81.4%), with HPV 52 as the most prevalent type (12.5%), followed by HPV 18 (6.7%), HPV 35 (5.8%), and HPV 70 (4.8%). Multiple HPV genotypes were observed in 17 (41%) of the 41 HPV- and HIV-positive men. In contrast, only 11 (9.6%) HPV DNA-positive cases were observed among the 115 HIV-uninfected men, and 3 (27.3%) contained multiple genotypes. Quantitative analyses indicated that the HPV viral load, as measured in urine samples, is significantly higher in HIV-positive men compared to HIV-negative men. In the present study we show that urine samples are useful for detecting HPV DNA, there is a high prevalence of HPV in HIV-positive men, and the HPV viral load is substantially higher in HIV-positive than in HIV-negative men. More studies are needed to evaluate the risk and natural development of HPV-related malignancies in HIV-positive men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333078      PMCID: PMC1317195          DOI: 10.1128/JCM.43.12.5936-5939.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Human papillomavirus infection and disease in HIV-infected individuals.

Authors:  Michael E Hagensee; Jennifer E Cameron; Janet E Leigh; Rebecca A Clark
Journal:  Am J Med Sci       Date:  2004-07       Impact factor: 2.378

2.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 3.  Anogenital neoplasia in AIDS.

Authors:  Mark H Einstein; Anna S Kadish
Journal:  Curr Opin Oncol       Date:  2004-09       Impact factor: 3.645

4.  Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Authors:  Anna-Barbara Moscicki; Jonas H Ellenberg; Sepideh Farhat; Jiahong Xu
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

5.  Impact of HIV infection on invasive cervical cancer in Kenyan women.

Authors:  Peter B Gichangi; Job Bwayo; Benson Estambale; Hugo De Vuyst; Shadrack Ojwang; Khama Rogo; Henry Abwao; Marleen Temmerman
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

6.  Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.

Authors:  Stephen E Hawes; Cathy W Critchlow; Mame A Faye Niang; Mame B Diouf; Aissatou Diop; Papa Touré; Abdoul Aziz Kasse; Birama Dembele; Papa Salif Sow; Awa M Coll-Seck; Jane M Kuypers; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2003-07-23       Impact factor: 5.226

7.  Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study.

Authors:  Eric M van der Snoek; Hubert G M Niesters; Paul G H Mulder; Gerard J J van Doornum; Albert D M E Osterhaus; Willem I van der Meijden
Journal:  Sex Transm Dis       Date:  2003-08       Impact factor: 2.830

Review 8.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

9.  High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse.

Authors:  Christophe Piketty; Teresa M Darragh; Maria Da Costa; Patrick Bruneval; Isabelle Heard; Michel D Kazatchkine; Joel M Palefsky
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

10.  Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.

Authors:  S J Weissenborn; A M Funke; M Hellmich; P Mallmann; P G Fuchs; H J Pfister; U Wieland
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  4 in total

Review 1.  Detection of human papillomavirus DNA in urine. A review of the literature.

Authors:  A Vorsters; I Micalessi; J Bilcke; M Ieven; J Bogers; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-05       Impact factor: 3.267

2.  Prevalence of High Risk HPV in HIV-Infected Women From Belém, Pará, Amazon Region of Brazil: A Cross-Sectional Study.

Authors:  Jacqueline Cortinhas Monteiro; Ricardo Roberto de Souza Fonseca; Tuane Carolina de Sousa Ferreira; Luana Lorena Silva Rodrigues; Andreza Reis Brasil da Silva; Samara Tatielle Gomes; Rodrigo Vellasco Duarte Silvestre; Andréa Nazaré Monteiro Rangel Silva; Ilze Pamplona; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado
Journal:  Front Public Health       Date:  2021-04-29

3.  Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.

Authors:  Zizipho Z A Mbulawa; David Coetzee; Anna-Lise Williamson
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

4.  The relationship between anogenital HPV types and incident HIV infection among men who have sex with men and transgender women in Lima, Peru: Findings from a prospective cohort study.

Authors:  Brandon Brown; Logan Marg; Segundo Leon; Cynthia Chen; Junice Ng Yi Siu; Gino Calvo; Hugo Sánchez; Jerome T Galea
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.